← Back to Search

Work-Focused Program for Substance Use Disorders

N/A
Recruiting
Led By Joanna M. Fiszdon, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be 18 years of age and older
Must be competent to give written informed consent and HIPAA authorization
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether work-focused programs can help Veterans in early recovery from substance use disorder achieve sobriety and other better clinical outcomes.

Who is the study for?
This trial is for Veterans diagnosed with any Substance Use Disorder (SUD) such as opioids or alcohol, who are enrolled in VACHS substance use treatment and are within 30 days of detoxification. Participants must be over 18, able to consent, and not planning to relocate or likely to be incarcerated during the study.
What is being tested?
The trial is testing if work-focused programs can help improve sobriety and overall functioning in Veterans recovering from SUDs. It randomly assigns participants to either receive a referral for these programs or continue with their usual treatment without additional work focus.
What are the potential side effects?
Since this trial involves referral to therapeutic work activities rather than medication, traditional side effects like those seen with drugs aren't expected. However, there may be stress or emotional impacts associated with participating in work-focused therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am able to understand and sign the consent form.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinical Global Impression
percent days abstinent
Secondary study objectives
change from baseline in BASIS-24
change from baseline in New General Self-Efficacy Scale
change from baseline in Rosenberg self-esteem scale
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: treatment as usual plus referral to work focused programExperimental Treatment2 Interventions
usual substance use treatment plus referral to a competitive or non-competitive work-focused program
Group II: treatment as usualActive Control1 Intervention
usual substance use treatment

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,643 Total Patients Enrolled
Joanna M. Fiszdon, PhDPrincipal InvestigatorVA Connecticut Healthcare System West Haven Campus, West Haven, CT
2 Previous Clinical Trials
220 Total Patients Enrolled

Media Library

treatment as usual Clinical Trial Eligibility Overview. Trial Name: NCT04969081 — N/A
Addiction Research Study Groups: treatment as usual, treatment as usual plus referral to work focused program
Addiction Clinical Trial 2023: treatment as usual Highlights & Side Effects. Trial Name: NCT04969081 — N/A
treatment as usual 2023 Treatment Timeline for Medical Study. Trial Name: NCT04969081 — N/A
~73 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top